Suppr超能文献

器官培养后甲状腺同种异体移植存活率的提高。组织免疫原性的改变。

Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.

作者信息

Hullett D A, Landry A S, Leonard D K, Sollinger H W

机构信息

Department of Surgery, University of Wisconsin Hospital, Madison 53792.

出版信息

Transplantation. 1989 Jan;47(1):24-7. doi: 10.1097/00007890-198901000-00006.

Abstract

Hyperbaric oxygen (95%, O2, 25 psi, 48-hr culture) resulted in prolonged thyroid allograft (B10.A) survival in both primary and sensitized recipients (B10.AQR). Recipients receiving noncultured thyroid allografts uniformly rejected the graft by 35 days, while 100% of cultured grafts survived. Noncultured thyroid grafts transplanted to skin-graft-primed recipients were rejected by 21 days. In contrast, 86% of cultured grafts transplanted to primed recipients were still functioning at 35 days. Donor spleen cells or peritoneal exudate cells transferred at the time of thyroid transplant were unable to stimulate cultured allograft rejection. Allografts histologically examined 35 days after transplant revealed, in some grafts, focal cellular infiltrates adjacent to normal, uninfiltrated tissue. To determine if tissue modification was the mechanism of prolonged allograft survival, hyperbaric-oxygen-cultured thyroids were examined for MHC class I expression. Immunoperoxidase staining with monoclonal antibody to MHC class I molecules showed that cultured thyroids were unstained in contrast to fresh thyroids that were uniformly stained. Cytotoxic T lymphocytes specific for H-2Kk administered 10 days following thyroid transplant were unable to eliminate cultured grafts (80% survival) but completely destroyed noncultured grafts. These results indicate that hyperbaric oxygen culture altered MHC class I expression such that it was no longer detectable by monoclonal antibody or cytotoxic T lymphocytes. Thus, the mechanism, explaining graft prolongation after hyperbaric culture in addition to passenger cell depletion, may be alteration of graft antigenicity such that the graft is no longer perceived as foreign.

摘要

高压氧(95%氧气,25磅力/平方英寸,48小时培养)可延长甲状腺同种异体移植物(B10.A)在初次和致敏受体(B10.AQR)中的存活时间。接受未培养甲状腺同种异体移植物的受体在35天内均排斥移植物,而100%的培养移植物存活。移植到经皮肤移植致敏受体的未培养甲状腺移植物在21天内被排斥。相比之下,移植到致敏受体的培养移植物在35天时仍有86%在发挥功能。甲状腺移植时转移的供体脾细胞或腹腔渗出细胞无法刺激培养的同种异体移植物排斥反应。移植后35天进行组织学检查的同种异体移植物显示,在一些移植物中,正常未浸润组织附近有局灶性细胞浸润。为了确定组织修饰是否是同种异体移植物存活延长的机制,对高压氧培养的甲状腺进行了MHC I类表达检测。用针对MHC I类分子的单克隆抗体进行免疫过氧化物酶染色显示,培养的甲状腺未染色,而新鲜甲状腺均被均匀染色。甲状腺移植10天后给予的针对H-2Kk的细胞毒性T淋巴细胞无法消除培养的移植物(80%存活),但能完全破坏未培养的移植物。这些结果表明,高压氧培养改变了MHC I类表达,使其不再能被单克隆抗体或细胞毒性T淋巴细胞检测到。因此,除了过客细胞耗竭外,解释高压培养后移植物存活延长的机制可能是移植物抗原性的改变,使得移植物不再被视为异物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验